LEVAFEN- carprofen tablet, chewable

Krajina: Spojené štáty

Jazyk: angličtina

Zdroj: NLM (National Library of Medicine)

Aktívna zložka:

CARPROFEN (UNII: FFL0D546HO) (CARPROFEN - UNII:FFL0D546HO)

Dostupné z:

ASPEN VETERINARY RESOURCES®, LTD

Spôsob podávania:

ORAL

Typ predpisu:

PRESCRIPTION

Terapeutické indikácie:

Levafen Chewable Tablets are indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. Levafen Chewable Tablets should not be used in dogs exhibiting previous hypersensitivity to carprofen.

Prehľad produktov:

Levafen Chewable Tablets are scored, and contain 25 mg, 75 mg, or 100 mg of carprofen per tablet. Each tablet size is packaged in bottles containing 30, 60, or 180 tablets.

Stav Autorizácia:

Abbreviated New Animal Drug Application

Súhrn charakteristických

LEVAFEN - CARPROFEN TABLET, CHEWABLE
ASPEN VETERINARY RESOURCES®, LTD
----------
LEVAFEN
(CARPROFEN)
CHEWABLE TABLETS
LEVAFEN
(CARPROFEN)
CHEWABLE TABLETS
_NON-STEROIDAL ANTI-INFLAMMATORY DRUG_
FOR ORAL USE IN DOGS ONLY
CAUTION:
Federal law restricts this drug to use by or on the order of a
licensed veterinarian.
DESCRIPTION:
Levafen™ (carprofen) Chewable Tablets are a non-steroidal
anti-inflammatory drug
(NSAID) of the propionic acid class that includes ibuprofen, naproxen,
and ketoprofen.
Carprofen is the nonproprietary designation for a substituted
carbazole, 6-chloro-α-
methyl-9_H_-carbazole-2-acetic acid. The empirical formula is C
H
CINO and the
molecular weight 273.72. The chemical structure of carprofen is:
Carprofen is a white, crystalline compound. It is freely soluble in
ethanol, but practically
insoluble in water at 25º C.
CLINICAL PHARMACOLOGY:
Carprofen is a non-narcotic, non-steroidal anti-inflammatory agent
with characteristic
analgesic and antipyretic activity approximately equipotent to
indomethacin in animal
TM
TM
15
12
2
1
models.
The mechanism of action of carprofen, like that of other NSAIDs, is
believed to be
associated with the inhibition of cyclooxygenase activity. Two unique
cyclooxygenases
have been described in mammals.
The constitutive cyclooxygenase, COX-1,
synthesizes prostaglandins necessary for normal gastrointestinal and
renal function.
The inducible cyclooxygenase, COX-2, generates prostaglandins involved
in
inflammation. Inhibition of COX-1 is thought to be associated with
gastrointestinal and
renal toxicity while inhibition of COX-2 provides anti-inflammatory
activity. The specificity
of a particular NSAID for COX-2 versus COX-1 may vary from species to
species.
In an
_in vitro_ study using canine cell cultures, carprofen demonstrated
selective inhibition of
COX-2 versus COX-1.
Clinical relevance of these data has not been shown. Carprofen
has also been shown to inhibit the release of several prostaglandins
in two inflammatory
cell systems: rat polymorphonuclear leukocyte